Conference abstract · 2012
Conference abstractPublished 22 Jan 2019
Potential therapeutic implications of gelsolin in Alzheimers disease
New York State Institute for Basic Research in Developmental Disabilities, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Deposition of fibrils Amyloid Beta-protein (Aβ) as amyloid plaques in the brain is a prominent feature in the pathology of AD. Gelsolin a multifunctional actin-binding protein is present as circulatory protein in plasma (p-gelsolin) and its shorter form is present in the cytoplasm (c-gelsolin). We have reported that gelsolin forms a complex with Aβ and gelsolin inhibits A fibrillization and it also solubilizes preformed Aβ fibrils. These findings suggest anti-amyloidogenic property of gelsolin. Other studies have also shown reduced amyloid load with peripheral administration of p-gelsolin or transgene expression of c-gelsolin in the transgenic mouse model of AD. The levels of gelsolin can also be increased epigenetically by inhibition of histone deacetylases, such as Trichostatin A (TSA). TSA has been reported to increase gelsolin expression in cell cultures and brain. We studied whether TSA can act as a potential therapeutic agent in AD through clearance of Aβ by affecting the levels of plasma/brain gelsolin in APPswe/PS1δE9 transgenic mouse model of AD. Intraperitoneal administration of TSA to these AD-tg mice for two months improved the learning ability during the Morris water maze training process. The western blots showed increased plasma levels of gelsolin, Aβ 1-40/Aβ 1-42 in TSA-treated mice as compared with vehicle-treated control mice. A positive correlation was observed between the plasma levels of gelsolin and Aβ 1-40 / Aβ 1-42 in AD-tg mice. These results suggest that TSA may help in Aβ clearance by inducing the expression of gelsolin, thus improving the learning skills. It seems that plasma gelsolin probably acts as peripheral sink protein to bind Aβ peptides and therefore help in Aβ clearance.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 11 Nov 2011
Long-term Electromagnetic Field Treatment Increases Brain Neuronal Activity: Linkage to Cognitive Benefit and Therapeutic Implications for Alzheimer's Disease
Research article · 30 Sep 2013
FTO Knockdown Decreases Phosphorylation of Tau in Neuronal Cells; A Potential Model Implicating the Association of FTO with Alzheimer 's Disease
Article · 16 Apr 2024
Orexin Signalling System?Potential Therapeutic Targets for Alzheimer's Disease and Various Mental Diseases
Research article · 2023
Orexin Signalling System—Potential Therapeutic Targets for Alzheimer's Disease and Various Mental Diseases
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ved Chauhan”
- BylineArticles whose byline prints “Abha Chauhan”
